The table below shows Cytosorbents Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$8.86M
$9.48M
$9.62M
$8.73M
$8.61M
$8.84M
Cost of revenue
$2.73M
$2.82M
$2.80M
$2.52M
$3.36M
$2.34M
Gross profit
$6.13M
$6.67M
$6.81M
$6.21M
$5.26M
$6.50M
R&D
$1.02M
-
-
$1.66M
$1.85M
$1.52M
CTSO annual revenue (10-K history)
Cytosorbents Corp reported annual revenue of $37.06M for fiscal year 2025. That is up 4.1% from $35.59M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.53M (FY 2016) to $37.06M. Figures come from the company's audited annual reports as filed with the SEC.